Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
11.01
-0.49 (-4.26%)
At close: Jul 17, 2026, 4:00 PM EDT
11.00
-0.01 (-0.09%)
After-hours: Jul 17, 2026, 4:10 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $19.27 million as of July 17, 2026. Its market cap has decreased by -46.77% in one year.
Market Cap
19.27M
Enterprise Value
17.24M
1-Year Change
-46.77%
Ranking
Category
Stock Price
$11.01
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $19.27M, a decrease of -93.39%. That is a compound annual growth rate of -22.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 19.27M | 45.65% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 21.27M |
| NextCure | 21.06M |
| Cellectar Biosciences | 20.70M |
| CEL-SCI | 20.27M |
| Atossa Therapeutics | 20.24M |
| Longeveron | 19.75M |
| Pluri | 19.69M |
| Allarity Therapeutics | 19.09M |